Detailed price information for 10X Genomics Inc (TXG-Q) from The Globe and Mail including charting and trades.

Learn more about whether Omnicell, Inc. or QuidelOrtho Corporation is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

The Pharmacy Automation Systems Market demonstrates strong growth potential, reflecting increasing investments in healthcare ...

Corey J Manley, EVP & Chief Legal/Admin Officer at Omnicell(NASDAQ:OMCL), executed an open-market sale of 6,106 shares for $243,629.40 on Dec. 3, 2025, as reported in the SEC Form 4 filing.

What financial metrics can indicate to us that a company is maturing or even in decline? When we see a declining return on capital employed (ROCE) in conjunction with a declining base of capital ...

If you are wondering whether Omnicell is attractively priced today, the key question is whether the current share price still lines up with the company’s underlying value. After a long stretch of ...

Omnicell (OMCL) shares added ~5% on Thursday after KeyBanc Capital Markets upgraded the MedTech, citing a "super-cycle" of growth post FY26 thanks to the company's new Titan XT dispensing cabinet and ...

Investing.com - KeyBanc Capital Markets upgraded Omnicell (NASDAQ:OMCL) from Sector Weight to Overweight with a price target of $60.00, citing a potential "super-cycle" of growth. The healthcare ...

Investing.com -- KeyBanc Capital Markets upgraded Omnicell to Overweight, saying the company is positioned for stronger revenue and earnings growth over the coming years as it enters in a potential ...

Medical Info Systems rides AI and telehealth tailwinds, lifting DOCS, TXG and OMCL, but cyber risks and industry underperformance keep optimism in check.

Investors in Omnicell, Inc. OMCL need to pay close attention to the stock based on moves in the options market lately. That is because the Feb 20, 2026 $17.50 Put had some of the highest implied ...